Slingshot members are tracking this event:
In February 2017, the data safety monitoring board recommended that FibroGen (FGEN) continue its Phase 3 roxadustat (FG-4592) programs
Slingshot Insights Explained
Feb 28, 2017
Don’t see a project related to the catalyst you care about?
Related Keywords Phase 3, Roxadustat, Independent Data Safety Monitoring Board, Fg-4592